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Abstract	16	
Post-thrombotic	syndrome,	a	 frequent	complication	of	deep	venous	thrombosis,	can	be	17	
reduced	with	early	vein	recanalization.	Pulsed	cavitational	therapy	(PCT)	using	ultrasound	is	18	
a	 recent	 non-invasive	 approach.	 We	 propose	 to	 test	 the	 efficacy	 and	 safety	 of	 high-19	
frequency	 focused	 PCT	 for	 drug-free	 thrombolysis	 (thrombotripsy)	 in	 a	 realistic	 in	 vitro	20	
model	of	venous	thrombosis.	21	
To	reproduce	venous	thrombosis	conditions,	human	whole	blood	was	allowed	to	clot	by	22	
stasis	in	silicone	tubes	(6	mm	internal	diameter)	at	a	30	cmH20	pressure,	maintained	during	23	
the	whole	 experiment.	We	 engineered	 an	 ultrasound	 device	 composed	 of	 dual	 2.25	MHz	24	
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Page 2 of 23	
transducers	centered	around	a	6	MHz	imaging	probe.	A	therapeutic	focus	was	generated	at	1	
a	3.2	cm	depth	from	the	probe.	Thrombotripsy	was	performed	by	longitudinally	scanning	the	2	
thrombus	at	3	different	speeds:	1	mm.s-1	(n=6);	2	mm.s-1	(n=	6);	3	mm.s-1	(n=	12).	Restored	3	
outflow	was	measured	every	3	passages.	Filters	were	placed	to	evaluate	the	debris	size.	4	
24	occlusive	 thrombi,	of	2.5	cm	mean	 length	and	4.4	kPa	mean	stiffness,	were	studied.	5	
Flow	restoration	was	systematically	obtained	by	9	subsequent	passages	(4.5	min	maximum).	6	
By	 varying	 the	 device’s	 speed,	we	 found	 an	 optimal	 speed	 of	 1	mm.s-1	 to	 be	 efficient	 for	7	
effective	recanalization	with	90	s	 (3	passages).	Within	90	s,	 flow	restoration	was	of	80,	62	8	
and	74	%	at	respectively	1,	2	and	3	mm.s-1.	For	all	groups,	cavitation	cloud	drilled	a	1.7	mm	9	
mean	diameter	channel	throughout	the	clot.	Debris	analysis	showed	92	%	of	debris	<10	μm,	10	
with	no	fragment	>	200	µm.		11	
	12	
CONCLUSION:	High-frequency	thrombotripsy	allowed	fast	and	effective	recanalization	of	13	
whole-blood	thrombus	in	vitro,	without	any	parietal	alteration	or	bulky	debris	formation.		14	
	15	
Keywords:	thrombolysis	–	histotripsy	–	venous	thrombosis	–	therapeutic	ultrasound	16	
Word	count:	abstract:	252	words,	manuscript	2860	words.	 	17	
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I. Purpose	1	
Deep	venous	thrombosis	of	the	lower	limbs	is	a	frequent	disease,	affecting	approximately	2	
0.1%	 to	 0.2%	 of	 people	 per	 year	 [1,	 2,	 3].	 The	 main	 initial	 risk	 is	 the	 migration	 of	3	
fibrinocruoric	emboli	responsible	for	pulmonary	embolism	in	about	30	%	of	cases	(Heit	et	al	4	
2016).	 In	 the	 long	 term,	 the	main	 risk	 for	proximal	 thrombosis	 is	 the	appearance	of	post-5	
thrombotic	 syndrome	 in	 about	 20	 to	 50	%	 of	 cases	 (Kahn	 et	 al	 2015),	 with	 an	 increased	6	
incidence	in	cases	of	iliofemoral	persistent	occlusion	(Delis	et	al	2004).	It	is	characterized	by	7	
functional	 impotence,	pain,	pruritus	and	distal	trophic	disorders,	with	a	major	alteration	of	8	
the	quality	 of	 life	 (Kahn	et	 al	 2008).	 Current	 treatment	 of	 venous	 thrombosis	 is	 based	on	9	
effective	anticoagulation,	expected	to	avoid	embolic	migration	and	to	reduce	morbidity	and	10	
mortality.	 On	 the	 other	 hand,	 anticoagulation	 is	 frequently	 inefficient	 for	 recanalizing	 the	11	
occluded	 vessel	 [6,	 7],	 	 with	 a	 consequently	 low	 influence	 on	 the	 incidence	 of	 post-12	
thrombotic	syndrome.	Several	studies	suggest	that	the	flow	restoration	in	the	occluded	vein	13	
allows	 for	 long-term	 venous	 recanalization	 and	 thus	 limits	 the	 risk	 of	 post-thrombotic	14	
syndrome	(Watson	and	Armon	2004,	Enden	et	al	2012).	The	use	of	plasminogen	activators	15	
or	 other	 thrombolytic	 agents	 has	 been	 shown	 to	 significantly	 improve	 the	16	
repermeabilization	 of	 the	 occluded	 vein.	 It	 was	 however	 associated	 with	 a	 10%	 rate	 of	17	
severe	 haemorrhagic	 events	 (Watson	 and	 Armon	 2004).	 Similarly,	 effective	 endovascular	18	
invasive	 recanalization	 procedures	 were	 associated	 with	 a	 decrease	 in	 post-thrombotic	19	
syndrome	at	6	weeks	(Enden	et	al	2012)	whereas	the	persistence	of	a	residual	thrombus	was	20	
associated	 with	 an	 increased	 risk	 of	 post-thrombotic	 syndrome	 (Comerota	 et	 al	 2012).	21	
However	this	intervention	is	associated	with	a	substantial	risk	of	hematoma,	false	aneurysm,	22	
reocclusion	or	stent	rupture.	23	
Therapeutic	ultrasound	has	been	investigated	by	several	groups	as	a	promising	drug-free	24	
approach	 for	 non-invasive	 recanalization	 in	 deep	 venous	 thrombosis	 settings.	 Various	25	
techniques	 such	 as	 histotripsy	 based	 on	 short	 high	 intensity	 ultrasound	 pulses	 or	 High	26	
Intensity	Focused	Ultrasound	(HIFU)	based	on	longer	excitation	pulses	have	been	proposed	27	
as	 a	 way	 to	 fragment	 thrombi	 by	 acoustic	 cavitation	 without	 the	 need	 of	 injecting	28	
microbubbles.	Vascular	wall	damage	can	however	be	observed	when	cavitation	occurs	near	29	
the	vessel	walls	(Maxwell	et	al	2009).	To	overcome	this	issue,	microtripsy	has	been	recently	30	
introduced	 to	generate	a	cavitation	cloud	contained	 in	a	 small	 volume,	 therefore	avoiding	31	
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any	damage	to	the	vessel	walls	(Zhang	et	al	2015b).	Microtripsy	requires	a	very	high	negative	1	
pressure	to	reach	the	intrinsic	cavitation	threshold	(–30	MPa),	which	remains	challenging	to	2	
achieve	 in	 vivo.	We	propose	 hereby	 an	 alternative	 approach	 by	 increasing	 the	 ultrasound	3	
frequency	(a	frequency	lower	than	1.5	MHz	is	used	in	most	histotripsy	applications)	in	order	4	
to	decrease	the	focus	size	and	achieve	very	accurate	fragmentation	of	the	thrombus	without	5	
damaging	 the	 vessel	walls.	 The	 goal	 of	 this	 study	was	 to	1)	 evaluate	 the	 feasibility	of	 this	6	
approach	on	an	in	vitro	model	of	human	blood	clot,	2)	assess	the	recanalization	efficacy	of	7	
pulsed	cavitational	ultrasound	and	3)	quantify	the	size	of	the	debris.	8	
II. Materials	and	methods	9	
1) Obtaining	an	occlusive	thrombus	10	
Human	 citrated	 (3.2%)	 whole	 blood	 was	 obtained	 from	 healthy	 volunteers	 from	 the	11	
French	Blood	Bank	Institute	(Etablissement	Français	du	Sang,	Paris,	France,	agreement	ref.	C	12	
CPSL	 UNT	 n°13/EFS/064).	 The	 subjects	 had	 normal	 complete	 blood	 count,	 denied	 having	13	
taken	 drugs	 interfering	 with	 haemostasis	 in	 the	 past	 10	 days	 and	 gave	 written	 informed	14	
consent.	 Coagulation	 was	 induced	 by	 adding	 20	 mM	 calcium	 chloride	 (CaCl2,	 number	 C	15	
5080;	 Sigma	 Chemical©,	 St.	 Louis,	 MO,	 USA).	 Aprotinin	 (100	 kIU/mL	 final	 concentration;	16	
Trasylol	500	000	kIU/50mL,	Bayer©)	was	added	to	block	the	endogenous	fibrinolysis	during	17	
the	recanalization	procedure.	Clots	of	2.5	cm	in	length	were	obtained	by	coagulation	under	18	
stasis	 at	 37	 °C	 in	 sealed	 roughened	 silicone	 tubes	 (6	mm	wide,	 1	mm	 thick,	 close	 to	 the	19	
characteristics	of	the	human	femoral	vein)	and	held	in	vertical	position	for	1	hour	after	the	20	
deposition	of	0.8	ml	of	citrated	whole	blood.	After	coagulation	and	thrombus	retraction,	the	21	
cap	was	removed	and	the	tube	placed	horizontally	and	charged	with	a	saline	solution	(0.9%	22	
NaCl)	via	a	pressure	column	at	30	cm	H2O.	Non-obstructive	thrombi	were	not	retained	for	23	
the	 experiments.	 The	 silicon	 tube	 was	 positioned	 in	 order	 to	 approach	 a	 realistic	 depth	24	
based	on	an	example	of	human	femoral	vein	(Figure	1).	25	
2) Thrombi	stiffness	evaluation	26	
Shear	 wave	 elastography	 was	 performed	 using	 a	 clinical	 ultrafast	 scanner	 (Aixplorer©,	27	
Supersonics	 Imagine©,	 Aix-en-Provence,	 France)	 and	 a	 linear	 ultrasound	 probe	 (SL10-2,	28	
central	frequency	6	MHz,	192	elements).	Thrombus	stiffness	was	obtained	by	measuring	the	29	
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mean	 elasticity	 of	 three	 circular	 regions	 of	 interest	 at	 a	 distance	 from	 the	walls	 to	 avoid	1	
interference	with	the	silicone	tube’s	wall	stiffness.	2	
3) Thrombotripsy	device	3	
Using	an	in-house	heterodyne	interferometer	(Royer	et	al	1992),	two	2.25	MHz	focused	4	
transducers	 (central	 frequency	2.25	MHz,	 focal	distance	38	mm,	F/D=1,	 Imasonic©,	Voray-5	
sur-l’Ognon,	France)	were	positioned	confocally	on	either	side	of	a	SL10-2	probe.	The	whole	6	
system	was	assembled	thanks	to	3D	printed	parts,	immersed	in	a	degassed	water-bath,	and	7	
moved	by	a	motor	along	the	silicone	tube.	The	focal	point	was	located	3.2	cm	away	from	the	8	
imaging	probe	(Figure	2).	The	size	of	the	focal	spot	(-6	dB)	in	the	plane	of	the	2	transducers	9	
was	0.45	x	1.25	mm	at	 low	pressure.	The	transducers	alone	had	a	theoretical	focal	spot	of	10	
0.67	mm	x	4.667	mm.	Using	these	two	aperture	confocal	transducers	allowed	reaching	high	11	
enough	 peak	 negative	 pressure	 for	 cavitation	 inception	 even	 though	 their	 aperture	 was	12	
small	 (38	mm	diameter). The	 use	 of	 two	 confocal	 transducers	 allowed	 reducing	 the	 non-13	
linear	propagation	effects	as	shown	in	simulation	by	Fowler	et	al.	and	Lafond	et	al.	(Fowler	14	
et	 al	 2013,	 Lafond	 et	 al	 2017).	 As	 a	 consequence,	 such	 a	 setup	 allowed	 a	 better	 spatial	15	
localization	of	 the	 focal	point	and	a	higher	negative	pressure	compared	 to	what	would	be	16	
generated	by	a	single	large	aperture.	The	two	transducers	were	driven	by	a	signal	generator	17	
(Tektronix©)	amplified	by	a	gain	of	60dB	by	a	2.5	kW	power	amplifier	 (GA-2500,	RITEC©,	18	
USA).	The	signals	were	composed	of	bursts	of	8-cycles	at	2.25	MHz	transmitted	with	a	Pulse	19	
Repetition	Frequency	(PRF)	of	100Hz.	The	negative	pressure’s	peak	generated	at	the	focus	of	20	
the	two	confocal	transducers	was	measured	with	an	optical	interferometer	at	–15	MPa.	21	
4) Recanalization:		22	
The	 SL10-2	probe	was	used	 to	 appropriately	 align	 the	device	with	 the	 tube	 in	order	 to	23	
place	the	focal	spot	in	the	center	of	the	tube.	Each	group	received	3	sequences	of	cavitation	24	
(1	sequence	=	3	passages)	along	the	thrombus,	with	assessment	of	the	restored	flow	after	25	
each	sequence.	One	passage	 is	the	displacement	of	the	device	along	the	thrombus	 length.	26	
We	fixed	three	different	passage	speeds	along	the	thrombus:	1	mm.s-1		(n=6;	1	passage=30	27	
s),	 2	 mm.s-1	 	 (n=6:	 1	 passage=15	 s)	 and	 3	mm.s-1	 (n=12;	 1	 passage=10	 s).	 Thus,	 the	 total	28	
cavitation	time	(3	sequences)	ranged	between	1.5	min	(at	3	mm.s-1)	to	4.5	min	(at	1	mm.s-1).	29	
The	drilled	channel	was	longitudinally	scanned	by	plane-by-plane	volumetric	acquisition	with	30	
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a	dedicated	probe	(SuperLinear™	Volumetric	SLV16-5,	Supersonics,	Aix	en	Provence,	France)	1	
to	assess	the	continuity	of	the	thrombus	recanalization.	2	
5) Outflow	evaluation	3	
After	each	sequence,	outflow	was	 investigated	by	measuring	the	volume	of	the	outflow	4	
solution	 for	 a	 defined	period	 of	 1	minute.	 Initial	 flow	measurement	was	 carried	 out	 after	5	
mounting	 the	 tube	 with	 the	 pressure	 column	 (30	 cmH2O	 i.e.	 22	 mmHg).	 Results	 are	6	
expressed	as	a	percentage	of	the	maximum	flow	rate	(flow	rate	measured	with	the	silicone	7	
tube	without	thrombus	under	the	same	conditions).	8	
6) Debris	analysis	9	
The	 outflow	 was	 filtered	 through	 2	 consecutive	 filters	 with	 100	 μm	 and	 40	 μm	 nylon	10	
mesh	 filters	 (Cell	 Stainer,	 BD	 Biosciences©).	 Each	 filter	 was	 rinsed	 with	 a	 saline	 solution,	11	
dried,	 and	 analysed	 under	 an	 optical	 microscope.	 Debris	 were	 counted	 by	 scanning	 the	12	
whole	 filter	 under	 a	microscope,	 using	 x100	 and	 x200	optical	magnifications.	 Small	 debris	13	
(<40	µm)	were	collected	and	then	analysed	by	sampling	using	a	computerised	counter	(Cell	14	
Counter	BioRad	Laboratory®).	The	diameter	distribution	of	the	small	debris	is	represented	by	15	
the	number	of	debris	normalized	to	the	removed	thrombus	volume.	16	
7) Statistical	analysis	17	
Continuous	 variables,	 presented	as	 their	mean	±	 standard	deviation,	were	 compared	with	18	
the	Mann–Whitney	U-test,	 or	 Kruskal–Wallis	 test	when	 comparing	more	 than	2	 groups	 (3	19	
different	speed	groups).	Variances	between	groups	were	compared	using	Levene’s	test	with	20	
a	Bonferroni	correction	for	multiple	comparisons.	Two-sided	p	values	<0.05	were	considered	21	
significant.	All	statistical	computations	used	the	R	software.	22	
III. Results	23	
Twenty-four	 consecutive	 adherent	 thrombi	 were	 evaluated.	 After	 1	 hour	 of	 clot	24	
formation	and	retraction,	the	thrombus	occupied	the	tube	volume	(6	mm	internal	diameter)	25	
and	2.51	cm	in	 length	on	average.	Only	occlusive	thrombi	were	retained,	with	a	microflow	26	
through	 the	 thrombus	 lower	 than	0.5	mL.min-1.	 Shear	wave	elastography	of	 the	 thrombus	27	
showed	 an	 average	 stiffness	 of	 4.4	 ±	 1.8	 kPa,	 corresponding	 to	 a	 recent	 deep	 venous	28	
thrombosis	(Mfoumou	et	al	2014).		29	
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1) Recanalization	efficiency:	1	
Histotripsy	 formed	 a	 circular	 channel	 of	 1.7	 ±	 0.4	 mm	mean	 cross	 sectional	 diameter	2	
throughout	the	clot	(the	average	volume	of	thrombus	removed	was	5.70	mm3)	(a	movie	of	3	
the	 recanalization	 procedure	 is	 presented	 in	 the	 supplementary	 materials).	 Transverse	4	
alignment	of	 the	device	made	 it	possible	to	center	the	cavitation	cloud	so	 it	did	not	reach	5	
the	 tube’s	 walls.	 End	 experiment	 examination	 revealed	 a	 residual	 thrombus	 coating	 the	6	
tube’s	inner	walls	of	2.1	mm	mean	thickness.	This	ensured	that	the	cavitation	cloud	was	well	7	
centered	and	far	from	the	tube’s	walls,	while	respecting	the	material’s	integrity	(Figure	3).		8	
2) Speed	and	time	for	thrombus	recanalization		9	
A	 speed	 of	 1	mm.s-1	 allowed	 efficient	 recanalization	 (80±7%)	 after	 only	 one	 sequence	 (3	10	
passages),	corresponding	to	a	treatment	duration	of	90	s	(Figure	4).	For	the	same	duration	11	
time,	we	obtained	only	61	±	32%	at	2	mm.s-1	and	74	±	22%	at	3	mm.s-1	(p=NS	for	all	groups).	12	
When	 comparing	 the	 time	 required	 for	 effective	 recanalization,	 regardless	 of	 the	13	
transducer’s	speed,	an	average	time	of	76	±	17	s	was	required	to	obtain	a	flow	recovery	at	14	
70%	and	101±45	s	for	a	flow	at	80%	of	the	initial	flow	(Figure	5).	However,	flow	restoration	15	
variance	 between	 thrombi	 recanalizations	was	 significantly	 lower	 at	 a	 speed	 of	 1	mm.s-1,	16	
7.4%,	compared	to	other	speeds	(32.5%	for	2	mm.s-1:	p=0.003;	22.4%	for	3	mm.s-1:	p=0.027).		17	
3) Debris	analysis	18	
Gross	 examination	 of	 the	 100	 µm	 filter	 at	 the	 end	 of	 each	 experiment	 revealed	 no	19	
macroscopic	 debris,	 whatever	 the	 speed	 group.	 Microscopic	 analysis	 of	 the	 nylon	 mesh	20	
filters	 	(Figure	6)	found	rare	debris	(1.6	±	1.7	per	thrombus)	but	none	bigger	than	200	µm,	21	
which	is	consistent	with	the	gross	examination	findings	(Figure	7).	The	small	debris	diameter	22	
distribution	(less	than	40	μm)	is	represented	in	Figure	8,	according	to	the	device’s	speed	and	23	
reported	 by	 the	 number	 of	 debris,	 normalized	 to	 the	 removed	 thrombus	 volume.	 No	24	
significant	 difference	 was	 noticed	 between	 the	 three	 groups	 of	 speed:	 p=0.30	 with	 the	25	
Kruskal-Wallis	 test.	 For	 the	absolute	number	of	 small	 debris,	 a	non-significant	 trend	 to	an	26	
increase	of	small	debris	was	observed	at	a	speed	of	1	mm.s-1,	which	corresponds	to	a	slightly	27	
larger	 volume	 of	 recanalized	 channel	 (89±29	mm3	 for	 1	mm.s-1	 vs.	 50±14	mm3	 for	 other	28	
speeds,	p=0.008)	with	a	lower	residual	thrombus	(1.93	±	0.20	vs.	2.20	±	0.11mm,	p=0.01).	29	
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IV. Discussion	1	
We	 aimed	 at	 demonstrating	 the	 effectiveness	 of	 thrombotripsy	 to	 recanalize	 a	 silicon	2	
tube	 containing	 an	 occlusive	 thrombus	 obtained	 with	 human	 whole	 blood	 stasis,	3	
reproducing	as	 closely	as	possible	 the	conditions	of	a	 recent	 femoral	 vein	 thrombosis.	 For	4	
this	reason,	we	performed	thrombus	 in	stasis	at	37°C,	 in	whole	blood	obtained	from	fresh	5	
human	blood.	Obtaining	 a	 thrombus	 adhering	well	 to	 the	walls	was	 an	 important	 step,	 in	6	
order	 to	 prevent	 the	migration	 of	 the	 entire	 thrombus	when	 loaded	with	 the	 pressurized	7	
saline	solution.	Moreover,	 it	avoided	the	use	of	stenosis	 to	block	the	clot	as	used	 in	other	8	
studies	 (Zhang	 et	 al	 2015a,	 2015b,	 2016).	We	 abandoned	 this	 procedure,	 first	 because	 it	9	
deviates	from	physiological	conditions,	second	because	when	recanalization	is	performed,	it	10	
turns	out	that	the	thrombus	migrates	inside	the	stenosis,	therefore	reducing	the	debris	to	be	11	
drained	 by	 the	 restored	 outflow.	Our	 initial	 use	 of	 a	 600	 kHz	 transducer	 failed	 to	 form	 a	12	
cavitation	 cloud	within	 the	 channel	 without	 creating	 cavitation	 on	 the	 outer	 walls	 of	 the	13	
tube.	This	shielding	reduced	the	acoustic	power	at	the	focus	depth	and	thus	the	cavitation	14	
activity	 in	 the	 channel.	Moreover,	 the	 formation	of	 a	 large	 cavitation	 cloud	could	damage	15	
the	 vessel	 walls.	 Depending	 on	 the	 emitted	 acoustic	 power,	 the	 cavitation	 cloud	 position	16	
varied	unpredictably.	17	
In	 our	 study,	 the	 use	 of	 higher	 frequency	 confocal	 transducers	 solved	 these	 issues.	 It	18	
allowed	forming	a	cloud	of	limited	size	with	isotropic	dimensions	(2x2x2	mm).	Compared	to	19	
large	 phased	 array	 systems	 powered	 with	 multi-channel	 electronics,	 this	 system	 was	20	
designed	and	built	at	a	much	lower	cost.	It	induced	a	complete	repeatability	of	the	cavitation	21	
cloud	position,	which	will	enable	a	higher	innocuousness	of	the	treatment	for	future	in	vivo	22	
trials.	23	
Sonothrombolysis	 usually	 corresponds	 to	 multiple	 techniques	 whose	 only	 common	24	
feature	 is	 the	 use	 of	 ultrasound	 during	 the	 thrombolysis	 procedure.	 The	main	 techniques	25	
developed	are	High	 Intensity	 Focused	Ultrasound	 (HIFU),	 for	which	 the	main	 advantage	 is	26	
the	use	of	the	thermal	properties	of	ultrasound	waves	to	facilitate	the	action	of	a	chemical	27	
thrombolysis	 (Bader	 et	 al	 2016,	 Wright	 et	 al	 2012).	 Thrombus	 fragmentation	 techniques	28	
using	 microbubbles	 underlined	 the	 mechanical	 thrombolytic	 effects	 of	 gas	 microbubbles,	29	
which	can	be	 injected	or	directly	 formed	by	cavitation	alone.	 In	order	to	develop	a	strictly	30	
non-invasive	 technique,	 our	 work	 stands	 on	 a	 model	 of	 cavitation	 alone,	 according	 to	31	
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previous	 work	 from	 the	 University	 of	Michigan	 [11,	 18,	 19,	 20].	 In	 order	 to	 improve	 this	1	
method,	 we	 used	 a	 higher	 frequency	 2-channel	 device,	 developed	 a	 model	 close	 to	 the	2	
human	venous	thrombosis	and	defined	the	optimal	therapeutic	time	for	a	recent	thrombus	3	
length	of	2.5	cm	as	studied	herein.	The	advantage	of	our	technique,	even	though	it	has	not	4	
been	tested	yet	in	vivo,	is	the	use	of	a	smaller	device,	easier	to	handle.	Cavitation	with	our	5	
device	can	be	achieved	with	commercially	available	generators	and	amplifiers.	6	
Flow	restoration	was	initiated	as	soon	as	a	little	channel	was	formed	along	the	thrombus,	7	
with	a	rapid	increase	during	the	procedure	related	to	the	channel	enlargement.	Longitudinal	8	
alignment	of	 the	thrombus,	with	control	of	 the	channel	drilling	throughout	the	procedure,	9	
allowed	 rapid	 recanalization	 by	 performing	 continuous	 cavitation	 with	 a	 fixed	 transducer	10	
speed.	11	
We	defined	the	1	mm.s-1	speed	as	the	optimal	speed	of	therapy	from	our	3	experimental	12	
conditions.	Indeed,	it	allowed	a	minimal	number	of	passages	(3)	to	achieve	the	optimal	flow	13	
rate	(>	80%)	with	a	short	time	of	therapy	(90	s).	The	time	required	to	recanalize	a	thrombus	14	
did	not	depend	significantly	on	 the	 speed.	At	higher	velocities	 (2	and	3	mm.s-1),	 complete	15	
recanalization	 required	more	passages,	which	 ended	 to	 the	 same	 recanalization	 than	 at	 1	16	
mm.s-1.	 We	 can	 note,	 however,	 that	 a	 higher	 variability	 of	 the	 recanalization	 time	 was	17	
observed	 at	 higher	 speed.	 We	 can	 anticipate	 that	 a	 lower	 speed	 would	 also	 provide	 a	18	
complete	recanalization,	but	it	would	require	longer	treatment	time,	which	would	increase	19	
the	 exposure	 risk	 of	 the	 vessel	 wall.	 Our	 objective	 being	 to	 allow	 a	 fast	 and	 safe	20	
recanalization,	we	 did	 not	 choose	 to	 explore	 lower	 speeds	 than	 1mm.s-1.	 This	method	 of	21	
longitudinal	 thrombolysis	 greatly	 shortened	 the	 procedure’s	 duration.	 However,	 this	22	
requires	 adapting	 the	 displacement	 of	 the	 transducer	 in	 order	 to	 follow	 the	 venous	23	
thrombus.	Such	a	device	can	be	developed	using	image	guidance	combined	to	a	robotic	arm.		24	
The	 purpose	 of	 the	 thrombus	 recanalization	 procedure	 was	 not	 to	 remove	 the	 entire	25	
thrombus	 clotted	 inside	 the	 tube	 but	 to	 create	 a	 small	 flowing	 channel	 in	 the	 clot.	26	
Recanalization	was	conducted	at	a	distance	from	the	tube’s	walls,	in	order	to	limit	as	much	27	
as	possible	the	risk	of	parietal	 injury.	Moreover,	even	with	a	small	diameter	channel,	good	28	
outflow	 (more	 than	 80%	 of	 the	 maximal	 flow)	 was	 obtained.	 Although	 the	 presence	 of	29	
residual	 thrombus	may	expose	 to	 the	 risk	of	post-procedure	venous	occlusion,	we	plan	 in	30	
further	 pre-clinical	 studies	 to	 perform	 the	 procedure	 under	 effective	 anticoagulation.	We	31	
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expect	 the	 recanalization	 to	 allow	 the	 heparin	 treatment	 to	 act	 locally	 and	maintain	 the	1	
vessel’s	permeability.	2	
Thrombus	 elastography	 was	 achieved	 to	 verify	 our	 thrombosis	 model.	 An	 average	3	
thrombus	elasticity	 of	 4.5	 kPa	was	 consistent	with	 the	maturation	 time	of	 1	 hour	 after	 in	4	
vitro	coagulation	induction.	According	to	the	study	carried	out	by	Mfoumou	et	al	[16],	with	5	
the	same	Aixplorer©	apparatus	on	in	vivo	thrombosis	in	the	rabbit,	5	kPa	thrombus	actually	6	
corresponded	 to	 a	 thrombus	 triggered	 in	 1	 to	 2	 hours.	 We	 did	 not	 test	 our	 device	 on	7	
thrombus	with	 a	higher	 stiffness,	 due	 to	 the	 conditions	needed	 for	 thrombus	maturation,	8	
with	a	progressive	enrichment	in	fibrin	as	well	as	the	loss	of	the	platelets,	which	could	not	be	9	
achieved	in	our	in	vitro	conditions.	10	
Debris	formation	is	inherent	to	any	recanalization	procedure.	The	release	of	small	debris	11	
is	necessary	to	allow	secure	venous	recanalization.	In	our	experiment,	we	did	not	notice	any	12	
macroscopic	debris	or	any	debris	with	a	diameter	over	200	µm.	Occlusion	of	the	pulmonary	13	
artery	 or	 its	 proximal	 branches,	 responsible	 for	 proximal	 pulmonary	 embolism	 is	 only	14	
triggered	 by	 bulky	 macroscopic	 thrombi.	 However,	 overall	 innocuousness	 of	 the	 debris	15	
obtained	is	difficult	to	assess	in	vitro.	During	a	perfusion	lung	scintigraphy,	between	200	000	16	
and	700	000	particles	of	albumin	aggregates	are	injected,	with	a	diameter	between	10	and	17	
90	µm	and	with	a	maximum	diameter	of	150	µm.	Even	though	albumin	aggregates	will	block	18	
some	lung	capillaries	(between	1/200	and	1/1000	(Dworkin	et	al	1966)),	this	examination	is	19	
considered	as	safe,	without	significant	hypoxemia	due	to	arteriolar	blockade	(Renowden	et	20	
al	 1991)	 and	 is	 performed	 in	 daily	 practice	 to	 diagnose	 pulmonary	 embolism.	We	mainly	21	
obtained	debris	corresponding	to	fragments	of	red	blood	cells,	size	<10	µm	not	threatening	22	
to	the	pulmonary	vascular	tree.	Debris	likely	to	obstruct	a	pulmonary	arteriole,	i.e.	over	100	23	
µm	diameter	in	theory,	were	very	scarce	(more	than	99%	of	the	debris	were	under	40	µm).	24	
The	risk	of	poor	tolerance	due	to	the	embolization	of	these	debris	is	therefore	very	low	with	25	
a	small	number	of	affected	arterioles.	26	
The	limitation	of	this	in	vitro	model	of	deep	venous	thrombosis	is	the	relatively	short	size	27	
of	 the	 thrombus.	This	 limits	 the	procedure	 to	 suspended	proximal	 thrombosis.	 Finally,	 the	28	
potential	danger	of	the	debris	requires	a	specific	evaluation	in	animals.	In	order	to	obtain	a	29	
sufficient	venous	diameter	close	 to	 the	human	femoral	vein,	 the	pig	model	 is	 the	smallest	30	
animal	model	appropriate	for	this	purpose,	as	already	tested	(Maxwell	et	al	2009,	Zhang	et	31	
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al	2017).	In	an	in	vivo	application,	we	need	to	consider	tissue	attenuation.	With	an	average	1	
depth	of	3	cm	of	the	femoral	vein	in	pig,	and	an	average	tissue	attenuation	of	0.6	dB.MHz-2	
1.cm-1,	 we	 expect	 a	 total	 attenuation	 of	 4.05	 dB	 with	 a	 2.25	 MHz	 transducer.	 This	3	
attenuation	 factor	 can	 be	 easily	 compensated	 by	 increasing	 the	 amplification	 gain	 by	 1.6	4	
fold.	 On	 the	 other	 hand	 with	 histotripsy,	 tissue	 heating	 remains	 limited	 due	 to	 the	 low	5	
energy	 transmitted.	With	 our	 setup	 at	 PRF	 of	 100Hz,	 the	 total	 temporal	 average	 acoustic	6	
power	transmitted	in	tissue	is	evaluated	to	be	less	than	1W	with	therefore	no	risk	of	heating	7	
the	tissue	on	the	beam	path.	8	
Our	 thrombotripsy	 device	 has	 demonstrated	 its	 efficacy	 and	 safety	 in	 a	 recanalization	9	
model	 close	 to	 the	 conditions	 of	 human	 deep	 venous	 thrombosis.	 We	 carried	 out	10	
recanalization	 through	 recent	 thrombi,	 at	 a	 distance	 from	 the	 vessel’s	 walls,	 without	11	
generating	 large	debris.	This	 first	experiment	 is	encouraging	 in	 the	development	of	a	non-12	
invasive	tool	for	venous	recanalization.	13	
	14	
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VI. Figures	Legends	1	
Fig.	 1.	 Comparison	of	 the	depth	 and	diameter	of	 the	 femoral	 vein	 in	 a	 patient	with	 an	2	
occlusive	thrombus	(A)	versus	the	parameters	used	in	our	setup	(B).	3	
Fig.	2.	 Illustration	of	 the	thrombotripsy	experimentation	setup	(A).	The	two	transducers	4	
are	coupled	and	centered	by	a	linear	probe	of	7	MHz	(B).	It	is	then	immerged	and	centered	5	
on	the	occlusive	thrombus	in	the	silicon	tube	(C).		6	
Fig.	3.	Imaging	of	a	recanalyzed	thrombus.	Ultrasonic	acquisition	before	thrombolysis	(A).	7	
Complete	 recanalization	 after	 3	 series	 of	 3	 passages	 of	 thrombotripsy	 (B).	 Volumetric	8	
acquisition	with	a	dedicated	probe	confirms	 the	 recanalization’s	continuity,	 remotely	 from	9	
the	walls	(C).	10	
Fig.	4.	Rate	of	recanalization	according	to	thrombotripsy	passages	and	device’s	speed:	1	11	
mm.s-1	 (red),	 2	 mm.s-1	 (purple),	 3	 mm.s-1	 (blue).	 The	 restored	 outflow	 is	 presented	 as	 a	12	
percentage	of	the	maximum	flow	(initial	flow	without	thrombus).	13	
Fig.	 5.	 Recanalization	 rate	 according	 to	 the	 cavitation	 time.	 The	 restored	 outflow	 is	14	
presented	as	a	percentage	of	the	maximum	flow	(initial	flow	without	thrombus).	15	
Fig.	 6.	 Setup	 for	 debris	 collection	 (A).	 The	100	µm	and	40	μm	 filters	 allowed	 to	 collect	16	
debris	>40	µm.	Pictures	B	and	C	show	debris	>100µm	and	pictures	D	and	E	show	debris	>40	17	
µm.	18	
Fig.	7.	Debris	count	>40μm	according	to	the	device’s	speed.	Debris	on	filters	of	40	µm	and	19	
100	μm	were	counted	under	light	microscopy.	20	
Fig.	8.	Small	debris	(<40	μm)	diameter	distribution	represented	by	the	number	of	debris	21	
standardized	to	the	removed	thrombus	volume.	Debris	count	was	obtained	by	the	automatic	22	
Counter	and	presented	according	to	device’s	speed. 	23	
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